Bacteria eradication reduces gastric cancer risk by 22 percent in over-60s, new research shows

Pinterest LinkedIn Tumblr +

Treating Helicobacter pylori (H. pylori) infection of the stomach could lead to a marked reduction in the risk of stomach cancer – particularly in the elderly – according to results of a study presented today at the 25th United European Gastroenterology Week in Barcelona.

The population-based study, which involved more than 63,000 people who had received antibiotic-based treatment for H. pylori infection, showed a 22% reduction in the risk of developing stomach cancer in those aged 60 years and over compared with the general population.

The research analysed the risk of gastric cancer development in a large group of individuals who had received antibiotic therapy to treat H. pylori infection – a type of bacteria that lives in the lining of the stomach.

Of those who had been treated over the age of 60, 0.8% developed gastric cancer, in comparison to 1.1% of patients in an age-matched general population sample.

Gastric cancer is the fourth largest cancer killer in the world, accounting for 754,000 deaths in 2015.

It mainly affects older people, with an average age of 69 years at the time of diagnosis.

Classified as a carcinogen by the International Agency for Research on Cancer, the H. pylori infection is the most significant factor leading to the development of gastric cancer, representing 78% of all global gastric cancer cases.

The infection is thought to affect more than 50% of the world’s population, although most people do not know that they are infected until they develop symptoms of gastric irritation, such as heartburn or dyspepsia.

A diagnosis is usually made using a blood or breath test, but can also be made through an endoscopy or a stool test.

Presenting the results of this major study at the Opening Plenary session of the 25th UEG Week in Barcelona, Professor WK Leung from the Department of Medicine at the University of Hong Kong, explained; “We saw a significantly lower risk of gastric cancer in people over 60 who received antibiotic therapy for their H. pylori infection, in comparison to the general population. The 22% reduction is remarkable, and suggests that there is real value in the treatment of this infection.”

“Although it has been commonly thought that it may be too late to give H. pylori eradication therapy to older subjects, we can now confidently recommend that the H. pylori infection should be treated in the elderly to help reduce their risk of developing gastric cancer” added Professor Leung.

SourceSpink Health


About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.